You Can’t Patent LSD

episode

Motley Fool Hidden Gems Investing not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Motley Fool Hidden Gems Investing

Musings About the Agentic Future 22 min · 23 Sep 2026

The Looming Constraint of the Space Industry 23 min · 22 Sep 2026

Diesel’s All-Time High 24 min · 21 Sep 2026

Harvard's Judgment Professor: The Curse of Optionality, and the One Habit That Builds Better Judgment 32 min · 20 Sep 2026

The Current State of the Financial Independence Movement 36 min · 19 Sep 2026

Consumer Check-In & AI’s Progress 38 min · 18 Sep 2026

All episodes from Motley Fool Hidden Gems Investing →

Report any issue

Source

Recorded23 Nov 2024

Publisherfeeds.megaphone.fm ↗

Handlerec:474990

Show notes

Mary Long caught up with Motley Fool Contributor Keith Speights to check in on the psychedelic industry. They discuss: - Advice to investors looking at a highly speculative industry. - The cash and regulatory questions for these companies. - Key differences between the cannabis market and psychedelic stocks. - The challenges of doing a double-blind test on psychedelic compounds. Companies discussed: CMPS, CYBN, ATAI Host: Mary Long Guest: Keith Speights Producer: Ricky Mulvey Engineers: Rick Engdahl, Desireé Jones Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in